46. Sarah Esther Chang et al., “NewOnset IgG Autoantibodies in Hospitalized Patients with COVID-19,” medRxiv (29 января 2021), doi: 10.1101/2021.01.27.21250559.
47. Mariam Ahmed Saad et al., “COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases,” Current Rheumatology Reviews 17, no. 2 (2021): 193–204, doi: 10.2174/15733 97116666201029155856.
48. Nahid Bhadelia et al., “Distinct Autoimmune Antibody Signatures Between Hospitalized Acute COVID-19 Patients, SARSCoV-2 Convalescent Individuals, and Unexposed PrePandemic Controls,” medRxiv (25 января 2021), doi: 10.1101/2021.01.21.21249176.
49. Shin Jie Yong et al., “Long COVID or PostCOVID-19 Syndrome: Putative Pathophysiology, Risk Factors, and Treatments,” Infectious Diseases 53, no. 10 (октябрь 2021): 737–754, doi: 10.1080/23744235.2021.1924397.
50. Aristo Vojdani and Datis Kharrazian, “Potential Antigenic CrossReactivity between SARSCOV-2 and Human Tissue with a Possible Link to an Increase in Autoimmune Diseases,” Journal of Clinical Immunology 217 (август 2020): 108480, doi: 10.1016/j.clim.2020.108480.
1. Bruce P. Lanphear, “The Impact of Toxins on the Developing Brain,” Annu Rev Public Health 36 (2015): 211–30, doi: 10.1146/annurevpublhealth031912114413.
2. Emily C. Somers et al., “Mercury Exposure and Antinuclear Antibodies among Females of Reproductive Age in the United States: NHANES,” Environmental Health Perspectives 123, no. 8 (август 2015): 792–798, doi: 10.1289/ehp.1408751.
3. EPA Press Office, “EPA Releases First Major Update to Chemicals List in 40 Years,” Environmental Protection Agency (19 февраля 2019), https://archive.epa.gov /epa/newsreleases/epareleasesfirstmajorupdatechemicalslist-40-years.html.
4. Vladimir N. Uversky et al., “Synergistic Effects of Pesticides and Metals on the Fibrillation of AlphaSynuclein: Implications for Parkinson’s Disease,” Neurotoxicology 23, nos. 4–5 (октябрь 2002): 527–536, doi: 10.1016/s0161813x(02)00067-0.
5. “National Report on Human Exposure to Environmental Chemicals: Updated Tables, March 2021,” Centers for Disease Control and Prevention, https://www.cdc.gov/exposurereport/.
6. “Group: EWG/Commonweal Study #1, Industrial Chemicals and Pesticides in Adults Found 155–171 of 214 Tested Chemicals (9 Participants),” Human Toxome Project, https://www.ewg.org/sites/humantoxome/participants/participantgroup.php?group=bb1.
7. “Body Burden: The Pollution in Newborns,” EWG (14 июля 2005), https://www.ewg.org/research/bodyburdenpollutionnewborns.
8. Rachel MorelloFrosch et al., “Environmental Chemicals in an Urban Population of Pregnant Women and Their Newborns from San Francisco,” Environmental Science & Technology 50, no. 22 (4 октября 2016): 12464–12472, doi: 10.1021/acs.est.6b03492.
9. Guomao Zheng et al., “Perand Polyfluoroalkyl Substances (PFAS) in Breast Milk: Concerning Trends for CurrentUse PFAS,” Environmental Science & Technology 55, no. 11 (13 мая 2021): 7510–7520, https://doi.org/10.1021/acs.est.0c06978.
10. Bevin E. Blake and Suzanne E. Fenton, “Early Life Exposure to Perand Polyfluoroalkyl Substances (PFAS) and Latent Health Outcomes: A Review Including the Placenta as a Target Tissue and Possible Driver of Periand Postnatal Effects,” Toxicology 443 (октябрь 2020): 152, doi: 10.1016/j.tox.2020.152565.
11. Fabrizia Bamonti et al., “Metal Chelation Therapy in Rheumatoid Arthritis: A Case Report. Successful Management of Rheumatoid Arthritis by Metal Chelation Therapy,” BioMetals 24, no. 6 (декабрь 2011): 1093–1098, doi: 10.1007/s105340119467-9.
12. Alessandro Fulgenzi et al., “A Case of Multiple Sclerosis Improvement Following Removal of Heavy Metal Intoxication: Lessons Learnt from Matteo’s Case,” BioMetals 25, no. 3 (март 2012): 569–576, doi: 10.1007/s105340129537-7.
13. M.P. Webber et al., “Nested CaseControl Study of Selected Systemic Autoimmune Diseases in World Trade Center Rescue/Recovery Workers,” Arthritis & Rheumatology 67, no. 5 (май 2015): 1369–1376, doi: 10.1002/art.39059.
14. Edith M. Williams et al., “A Geographic Information Assessment of Exposure to a Toxic Waste Site and Development of Systemic Lupus Erythematosus (SLE): Findings from the Buffalo Lupus Project,” Journal of Toxicology and Environmental Health Sciences 3, no. 3 (март 2011): 52–64, https://scholarcommons.sc.edu/cgi/viewcontent.cgi?article =1004 &context =sph _epidemiology_biostatistics_facpub.
15. Edith M. Williams et al., “A Case Study of Community Involvement Influence on Policy Decisions: Victories of a CommunityBased Participatory Research Partnership,” International Journal of Environmental Research and Public Health 13, no. 5 (20 мая 2016): 515, doi: 10.3390 /ijerph13050515
16. Yanpei Gu et al., “Biomarkers, Oxidative Stress and Autophagy in Skin Aging,” Ageing Research Reviews 59 (24 февраля 2020): 101036, doi: 10.1016/j.arr.2020.101036.
17. Sheetal Ramani et al., “Oxidative Stress in Autoimmune Diseases: An Under Dealt Malice,” Current Protein & Peptide Science 21, no. 6 (2020): 611–621, doi: 10.2174/138920372166620 0214111816; Shunichi Kumagai, Takumi Jikimoto, and Jun Saegusa, “Pathological Roles of Oxidative Stress in Autoimmune Diseases,” Rinsho Byori (Japanese Journal of Clinical Pathology) 51, no. 2 (февраль 2003): 126–132, https://pubmed.ncbi.nlm.nih.gov/12690629/.
18. Dorothy J. Pattison et al., “Dietary BetaCryptoxanthin and Inflammatory Polyarthritis: Results from a Populationbased Prospective Study,” The American Journal of Clinical Nutrition 82, no. 2 (август 2005): 451–455, doi: 10.1093/ajcn.82.2.451.
19. Lindsey A. Criswell et al., “Smoking Interacts with Genetic Risk Factors in the Development of Rheumatoid Arthritis among Older Caucasian Women,” Annals of the Rheumatic Diseases 65, no. 9 (сентябрь 2006): 1163–1167, doi: 10.1136/ard.2005.049676.
20. Eyal Zifman et al., “Antioxidants and Smoking in Autoimmune Disease— Opposing Sides of the Seesaw?”, Autoimmunity Reviews 8, no. 2 (декабрь 2008): 165–169, doi: 10.1016/j.autrev.2008.06.011.
21. JianHua Wang et al., “Acupuncture for Smoking Cessation: A Systematic Review and MetaAnalysis of 24 Randomized Controlled Trials,” Tobacco Induced Diseases 17 (4 июня 2019): 48, doi: 10.18332/tid/109195.
22. Margaret Sears E et al. “Arsenic, Cadmium, Lead, and Mercury in Sweat: A Systematic Review,” Journal of Environmental and Public Health Vol. 2012 (февраль 2012): 184745, doi: 10.1155/2012/184745.
23. Margaret Sears E et al. “Arsenic, Cadmium, Lead, and Mercury in Sweat: A Systematic Review,” Journal of Environmental and Public Health Vol. 2012 (февраль 2012): 184745, doi: 10.1155/2012/184745.
24. Stephen J. Genuis et al., “Blood, Urine, and Sweat (BUS) Study: Monitoring and Elimination of Bioaccumulated Toxic Elements,” Archives of Environmental Contamination and Toxicology 61, no. 2 (август 2011): 344–357, doi: 10.1007/s002440109611-5.
25. Geary W. Olsen et al., “HalfLife of Serum Elimination of Perfluorooctanesulfonate, Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers,” Environmental Health Perspectives 115, no. 9 (сентябрь 2007): 1298–1305, doi: 10.1289 /ehp.10009.
26. US Food and Drug Administration, “Recommendations About the Use of Dental Amalgam in Certain HighRisk Populations: FDA Safety Communication,” сентябрь 2020, https://www.fda.gov/medicaldevices/safetycommunications/recommendationsaboutusedental-amalgamcertainhighriskpopulationsfdasafetycommunication.
27. US Food and Drug Administration, “Recommendations”.
28. “Basic Information about Mercury,” United States Environmental Protection Agency, https://www.epa.gov/mercury/basicinformationaboutmercury.
29. Monisha Jaishankar et al., “Toxicity, Mechanism and Health Effects of Some Heavy Metals,” Interdisciplinary Toxicology 7, no. 2 (июнь 2014): 60–72, doi: 10.2478/intox20140009.
30. Somers, “Mercury Exposure,” 792–798.
31. Ahmad Movahedian Attar et al., “Serum Mercury Level and Multiple Sclerosis,” Biological Trace Element Research 146 (2012): 150–153, doi: 10.1007/s120110119239-y.
32. Benjamin Rowley and Marc Monestier, “Mechanisms of Heavy Metalinduced Autoimmunity,” Molecular Immunology 42, no. 7 (май 2005): 833–838, doi: 10.1016/j.molimm.2004.07.050.
33. Glinda S. Cooper et al., “Occupational Risk Factors for the Development of Systemic Lupus Erythematosus,” The Journal of Rheumatology 31, no. 10 (октябрь 2004): 1928–1933, https:// pubmed.ncbi.nlm.nih.gov/15468355/.
34. Frank C. Arnett et al., “Urinary Mercury Levels in Patients with Autoantibodies to U3-RNP (Fibrillarin),” The Journal of Rheumatology 27, no. 2 (февраль 2000): 405–410, https://pubmed.ncbi.nlm.nih.gov/10685806/.
35. Jennifer F. Nyland et al., “Biomarkers of Methylmercury Exposure Immunotoxicity among Fish Consumers in Amazonian Brazil,” Environmental Health Perspectives 119, no. 12 (декабрь 2011): 1733–1738, doi: 10.1289/ehp.1103741.
36. Carolyn M. Gallagher and Jaymie R. Meliker, “Mercury and Thyroid Autoantibodies in U.S. Women, NHANES 2007–2008,” Environment International 40 (апрель 2012): 39–43, doi: 10.1016/j.envint.2011.11.014.
37. Jaishankar, “Toxicity,” 60–72.
38. “Regulations for Lead Emissions from Aircraft,” United States Environmental Protection Agency, https://www.epa.gov/regulationsemissionsvehiclesandengines/regulations-lead-emissions – aircraft.
39. “Lead in Food, Food-wares, and Dietary Supplements,” U.S. Food & Drug Administration (27 февраля 2020), https://www.fda.gov/food/metalsandyourfood/lead food food-wares-and – dietary-supplements.